EP3645728A4 - Nouveaux orthologues de crispr de type vi et systèmes associés - Google Patents

Nouveaux orthologues de crispr de type vi et systèmes associés Download PDF

Info

Publication number
EP3645728A4
EP3645728A4 EP18824952.8A EP18824952A EP3645728A4 EP 3645728 A4 EP3645728 A4 EP 3645728A4 EP 18824952 A EP18824952 A EP 18824952A EP 3645728 A4 EP3645728 A4 EP 3645728A4
Authority
EP
European Patent Office
Prior art keywords
systems
novel type
crispr orthologs
orthologs
crispr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18824952.8A
Other languages
German (de)
English (en)
Other versions
EP3645728A1 (fr
Inventor
Feng Zhang
Omar O. Abudayyeh
David Benjamin Turitz Cox
Jonathan S. Gootenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Massachusetts Institute of Technology
Broad Institute Inc
Original Assignee
Harvard College
Massachusetts Institute of Technology
Broad Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Massachusetts Institute of Technology, Broad Institute Inc filed Critical Harvard College
Publication of EP3645728A1 publication Critical patent/EP3645728A1/fr
Publication of EP3645728A4 publication Critical patent/EP3645728A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/85—Fusion polypeptide containing an RNA binding domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP18824952.8A 2017-06-26 2018-06-26 Nouveaux orthologues de crispr de type vi et systèmes associés Pending EP3645728A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762525165P 2017-06-26 2017-06-26
US201762566851P 2017-10-02 2017-10-02
PCT/US2018/039595 WO2019005866A1 (fr) 2017-06-26 2018-06-26 Nouveaux orthologues de crispr de type vi et systèmes associés

Publications (2)

Publication Number Publication Date
EP3645728A1 EP3645728A1 (fr) 2020-05-06
EP3645728A4 true EP3645728A4 (fr) 2021-03-24

Family

ID=64741890

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18824952.8A Pending EP3645728A4 (fr) 2017-06-26 2018-06-26 Nouveaux orthologues de crispr de type vi et systèmes associés

Country Status (2)

Country Link
EP (1) EP3645728A4 (fr)
WO (1) WO2019005866A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
CA2935960C (fr) 2014-01-08 2023-01-10 Bart Lipkens Dispositif d'acoustophorese avec double chambre acoustophoretique
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11104937B2 (en) 2017-03-15 2021-08-31 The Broad Institute, Inc. CRISPR effector system based diagnostics
US11174515B2 (en) 2017-03-15 2021-11-16 The Broad Institute, Inc. CRISPR effector system based diagnostics
WO2018183908A1 (fr) 2017-03-31 2018-10-04 Dana-Farber Cancer Institute, Inc. Compositions et méthodes de traitement de tumeurs ovariennes
US11618928B2 (en) 2017-04-12 2023-04-04 The Broad Institute, Inc. CRISPR effector system based diagnostics for malaria detection
JP2020537121A (ja) 2017-10-04 2020-12-17 ザ・ブロード・インスティテュート・インコーポレイテッド Ｃｒｉｓｐｒエフェクター系に基づく診断
US11332736B2 (en) 2017-12-07 2022-05-17 The Broad Institute, Inc. Methods and compositions for multiplexing single cell and single nuclei sequencing
BR112020009889A2 (pt) 2017-12-14 2020-11-03 Flodesign Sonics, Inc. acionador e controlador de transdutor acústico
US11957695B2 (en) 2018-04-26 2024-04-16 The Broad Institute, Inc. Methods and compositions targeting glucocorticoid signaling for modulating immune responses
MX2020013836A (es) 2018-06-26 2021-05-27 Massachusetts Inst Technology Métodos, sistemas y diagnósticos de amplificación basados en el sistema efector crispr.
BR112020026246A2 (pt) 2018-06-26 2021-04-20 The Broad Institute Inc. composições, sistemas e métodos de amplificação com base em nickase dupla crispr
WO2020124050A1 (fr) 2018-12-13 2020-06-18 The Broad Institute, Inc. Dosages en mosaïque à l'aide d'une détection basée sur crispr-cas
US11739156B2 (en) 2019-01-06 2023-08-29 The Broad Institute, Inc. Massachusetts Institute of Technology Methods and compositions for overcoming immunosuppression
CN110157695A (zh) * 2019-01-25 2019-08-23 南昌大学 一种植物RNA m5C甲基化修饰的系统及方法
US20220154258A1 (en) 2019-03-14 2022-05-19 The Broad Institute, Inc. Crispr effector system based multiplex diagnostics
US20220177863A1 (en) 2019-03-18 2022-06-09 The Broad Institute, Inc. Type vii crispr proteins and systems
EP3979832A4 (fr) * 2019-06-06 2023-06-21 Tata Consultancy Services Limited Procédé et système d'identification de sites cibles candidats pour lutter contre des agents pathogènes
WO2021046257A1 (fr) 2019-09-03 2021-03-11 The Broad Institute, Inc. Diagnostic du cancer multiplex basé sur un système effecteur crispr
US11844800B2 (en) 2019-10-30 2023-12-19 Massachusetts Institute Of Technology Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
US20230374528A1 (en) * 2020-08-17 2023-11-23 University Of Maryland, College Park Compositions, systems, and methods for orthogonal genome engineering in plants
CA3222023A1 (fr) 2021-06-01 2022-12-08 Arbor Biotechnologies, Inc. Systemes d'edition de genes comprenant une nuclease crispr et leurs utilisations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016205764A1 (fr) * 2015-06-18 2016-12-22 The Broad Institute Inc. Nouvelles enzymes crispr et systèmes associés
WO2016205749A1 (fr) * 2015-06-18 2016-12-22 The Broad Institute Inc. Nouvelles enzymes crispr et systèmes associés
WO2018107129A1 (fr) * 2016-12-09 2018-06-14 The Broad Institute, Inc. Diagnostics basés sur un système effecteur crispr

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016205764A1 (fr) * 2015-06-18 2016-12-22 The Broad Institute Inc. Nouvelles enzymes crispr et systèmes associés
WO2016205749A1 (fr) * 2015-06-18 2016-12-22 The Broad Institute Inc. Nouvelles enzymes crispr et systèmes associés
WO2018107129A1 (fr) * 2016-12-09 2018-06-14 The Broad Institute, Inc. Diagnostics basés sur un système effecteur crispr

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019005866A1 *
SHMAKOV SERGEY ET AL: "Diversity and evolution of class 2 CRISPR-Cas systems", NATURE REVIEWS. MICROBIOLOGY, NATURE PUBLISHING GROUP, ENGLAND, vol. 15, no. 3, 23 January 2017 (2017-01-23) - 1 March 2017 (2017-03-01), pages 169 - 182, XP002767857, ISSN: 1740-1534, DOI: 10.1038/NRMICRO.2016.184 *

Also Published As

Publication number Publication date
WO2019005866A1 (fr) 2019-01-03
EP3645728A1 (fr) 2020-05-06

Similar Documents

Publication Publication Date Title
EP3655530A4 (fr) Nouveaux orthologues de crispr de type vi et systèmes associés
EP3645728A4 (fr) Nouveaux orthologues de crispr de type vi et systèmes associés
EP3727469A4 (fr) Nouveaux systèmes et enzymes crispr
EP3755792A4 (fr) Nouveaux orthologues de cas9
EP3500671A4 (fr) Systèmes et nouvelles enzymes crispr et systèmes
EP3500670A4 (fr) Nouveaux systèmes et enzymes crispr
IL281159A (en) New CRISPR enzymes and systems
EP3545085A4 (fr) Systèmes crispr/cpf1 et méthodes
HK1253001A1 (zh) 新型crispr酶以及系统
EP3679130A4 (fr) Systèmes de diagnostic à base de crispr multi-effecteur
SG10202010311SA (en) Novel Crispr Enzymes and Systems
EP3681888A4 (fr) Composés de pyrazolopyrimidinone et leurs utilisations
EP3313530A4 (fr) Dérivés de 4,6-pyrimidinylène et utilisations de ceux-ci
EP3387196A4 (fr) Systèmes d'attache poutre-poteau et charpentes résistantes aux moments et comportant ces systèmes
EP3719424A4 (fr) Réfrigérateur et système de réfrigération
EP3654982A4 (fr) Composés de 1,8-naphthyridinone et leurs utilisations
EP3700934A4 (fr) Composés et utilisations de ces composés
EP3884065A4 (fr) Procédés, systèmes et compositions de bibliothèque directe
EP3359676A4 (fr) Système de transposon, kit le comprenant et utilisations correspondantes
EP3692008A4 (fr) Procédés et systèmes de biocimentation
EP3585511A4 (fr) Molybdène-métal et son procédé de fabrication
EP3551619A4 (fr) Compositions comprenant des promédicaments méthylphénidates, procédés de fabrication et d'utilisation de ces compositions
EP3720281A4 (fr) Compositions pesticides et procédés associés
EP3697409A4 (fr) Compositions de cannabidiol et de chitosane et leurs procédés d'utilisation
EP3612230A4 (fr) Compositions de palbociclib et méthodes associées

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210219

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/63 20060101AFI20210216BHEP

Ipc: C12N 15/82 20060101ALI20210216BHEP

Ipc: C12N 9/22 20060101ALI20210216BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20221121

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230527